MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats SLS Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Stock Rises 57 KZIA Q1 2026 Earnings EPS Misses Expectations Amid Clinical Progress Stock Rises PAC Q1 2026 Earnings EPS Surpasses Estimates by 16 Stock Declines Slightly CIMP Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Performance